IBIO - Micro-Cap Stock iBio Doubles On Wednesday - Here's Why | Benzinga
iBio Inc (NYSE:IBIO) shares are surging after the company entered into a collaboration agreement with AstralBio Inc. on Wednesday to discover, engineer, and develop antibodies to treat obesity and other cardiometabolic conditions.
The shares are trading over 100% with a strong session volume of 38.98 million compared to an average volume of average Volume 106.958K as per data from Benzinga Pro.
This micro-cap biotech player is valued at $4 million, with an enterprise value of $17.7 million.
Tuesday, iBio announced the closing of a $15 million ...